Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine

Overview of attention for article published in Frontiers in Medical Technology, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 259)
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 18 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Emerin deficiency drives MCF7 cells to an invasive phenotype

Article in Scientific Reports (August 2024)

Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis

Article in Cytokine & Growth Factor Reviews (August 2024)

Preclinical evaluation of dalbergin loaded PLGA-galactose-modified nanoparticles against hepatocellular carcinoma via inhibition of the AKT/NF-κB signaling pathway

Article in International Immunopharmacology (August 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.